SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-18-007290
Filing Date
2018-08-30
Accepted
2018-08-30 07:08:04
Documents
39
Period of Report
2018-08-31

Document Format Files

Seq Description Document Type Size
1 6-K rdhl-20180831x6k.htm 6-K 22771
2 EX-1 rdhl-20180831ex142a1a885.htm EX-1 417526
3 EX-2 rdhl-20180831xex2.htm EX-2 675226
  Complete submission text file 0001558370-18-007290.txt   3104258

Data Files

Seq Description Document Type Size
4 EX-101.INS rdhl-20180831.xml EX-101.INS 542273
5 EX-101.SCH rdhl-20180831.xsd EX-101.SCH 27903
6 EX-101.CAL rdhl-20180831_cal.xml EX-101.CAL 34986
7 EX-101.DEF rdhl-20180831_def.xml EX-101.DEF 59564
8 EX-101.LAB rdhl-20180831_lab.xml EX-101.LAB 223863
9 EX-101.PRE rdhl-20180831_pre.xml EX-101.PRE 143453
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 181045511
SIC: 2834 Pharmaceutical Preparations